- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 14 residues within 4Å:- Chain A: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain B: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.1, POV.6, POV.18
14 PLIP interactions:6 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:L.1071, B:F.1074, B:F.1074, B:F.1074, B:L.1075, B:V.1078, A:L.966, A:I.969, A:F.970, A:F.970, A:F.970
- Hydrogen bonds: A:Y.922, A:S.926, A:S.926
CLR.22: 15 residues within 4Å:- Chain B: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain C: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.19, POV.24, POV.25, POV.33
15 PLIP interactions:9 interactions with chain B, 6 interactions with chain C- Hydrophobic interactions: B:L.966, B:I.969, B:I.969, B:F.970, B:F.970, B:F.970, C:L.1071, C:F.1074, C:F.1074, C:F.1074, C:L.1075, C:V.1078
- Hydrogen bonds: B:Y.922, B:S.926, B:S.926
CLR.37: 15 residues within 4Å:- Chain C: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain D: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.34, POV.39, POV.40, POV.49
14 PLIP interactions:8 interactions with chain C, 6 interactions with chain D- Hydrophobic interactions: C:L.966, C:I.969, C:F.970, C:F.970, C:F.970, D:L.1071, D:F.1074, D:F.1074, D:F.1074, D:L.1075, D:V.1078
- Hydrogen bonds: C:Y.922, C:S.926, C:S.926
CLR.52: 14 residues within 4Å:- Chain A: W.1070, L.1071, F.1074, L.1075, V.1078
- Chain D: Y.922, S.926, L.966, I.969, F.970, V.973
- Ligands: POV.16, POV.50, POV.54
15 PLIP interactions:6 interactions with chain A, 9 interactions with chain D- Hydrophobic interactions: A:L.1071, A:F.1074, A:F.1074, A:F.1074, A:L.1075, A:V.1078, D:L.966, D:I.969, D:I.969, D:F.970, D:F.970, D:F.970
- Hydrogen bonds: D:Y.922, D:S.926, D:S.926
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.13: 19 residues within 4Å:- Chain A: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Chain D: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Ligands: POV.12, POV.18, POV.48, POV.59
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:W.1029, A:A.1032, A:I.1035, D:L.863, D:M.867, D:T.870, D:F.871
- Hydrogen bonds: A:P.1027
DU0.31: 19 residues within 4Å:- Chain A: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain B: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.11, POV.14, POV.30, POV.33
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:L.863, A:L.866, A:M.867, A:T.870, A:F.871, A:Y.972, B:W.1029, B:A.1032, B:I.1035
- Hydrogen bonds: B:P.1027
DU0.46: 19 residues within 4Å:- Chain B: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain C: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.29, POV.32, POV.45, POV.49
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:W.1029, C:A.1032, C:I.1035, B:L.863, B:M.867, B:T.870
- Hydrogen bonds: C:P.1027
DU0.61: 19 residues within 4Å:- Chain C: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain D: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.16, POV.44, POV.47, POV.60
8 PLIP interactions:4 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:W.1029, D:A.1032, D:I.1035, C:L.863, C:L.866, C:M.867, C:T.870
- Hydrogen bonds: D:P.1027
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.